DOCSLIB.ORG

Mouse Clstn1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Clstn1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Clstn1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Clstn1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Clstn1 gene (NCBI Reference Sequence: NM_023051 ; Ensembl: ENSMUSG00000039953 ) is located on Mouse chromosome 4. 19 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 19 (Transcript: ENSMUST00000039144). Exon 3~4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Clstn1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP24-391E9 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Juvenile mice homozygous for a null allele show reduced basal excitatory synaptic transmission, abnormal excitatory postsynaptic currents, enhanced NMDA receptor-dependent long term potentiation, and delayed dendritic spine maturation in CA1 hippocampal pyramidal cells. Exon 3 starts from about 7.32% of the coding region. The knockout of Exon 3~4 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 11914 bp, and the size of intron 4 for 3'-loxP site insertion: 1895 bp. The size of effective cKO region: ~1821 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 3 4 5 19 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Clstn1 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(8321bp) | A(25.78% 2145) | C(23.92% 1990) | T(26.73% 2224) | G(23.58% 1962) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr4 + 149622838 149625837 3000 browser details YourSeq 267 1 476 3000 88.0% chr7 + 43407213 43407650 438 browser details YourSeq 238 1 476 3000 90.8% chr7 + 43407015 43407598 584 browser details YourSeq 235 5 421 3000 87.6% chr8 - 76619560 76620036 477 browser details YourSeq 233 1 452 3000 90.0% chr5 - 119924956 119925540 585 browser details YourSeq 224 1 464 3000 90.1% chr6 - 139721437 139721924 488 browser details YourSeq 217 1 420 3000 93.0% chr5 - 76757986 76758547 562 browser details YourSeq 215 2 432 3000 89.1% chr12 - 76179883 76180419 537 browser details YourSeq 214 1 364 3000 90.4% chr3 - 9049902 9050307 406 browser details YourSeq 208 34 463 3000 85.8% chr11 + 120439874 120440230 357 browser details YourSeq 205 1 400 3000 85.7% chr5 + 144277828 144278159 332 browser details YourSeq 202 3 394 3000 90.2% chr11 + 118886919 118887492 574 browser details YourSeq 197 5 388 3000 89.5% chr9 - 101057985 101058692 708 browser details YourSeq 195 2 497 3000 90.3% chr11 + 109877562 109878465 904 browser details YourSeq 191 2 479 3000 84.7% chr11 + 97620979 97621328 350 browser details YourSeq 186 1 440 3000 82.7% chr4 - 32356662 32356937 276 browser details YourSeq 185 3 406 3000 90.0% chr8 - 76619465 76620006 542 browser details YourSeq 182 28 452 3000 83.1% chr12 - 76180051 76180397 347 browser details YourSeq 179 1 380 3000 83.9% chr5 + 144277882 144278157 276 browser details YourSeq 177 1 338 3000 87.1% chr3 - 9049918 9050227 310 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr4 + 149627659 149630658 3000 browser details YourSeq 193 2467 2734 3000 91.1% chr4 + 134101107 134101553 447 browser details YourSeq 190 2466 2734 3000 92.2% chr5 - 29732685 29733339 655 browser details YourSeq 189 2456 2737 3000 91.1% chr19 - 4278567 4279167 601 browser details YourSeq 154 2428 2620 3000 93.3% chr10 - 52291175 52303254 12080 browser details YourSeq 151 2428 2612 3000 91.8% chr14 - 30841479 30841671 193 browser details YourSeq 151 2475 2684 3000 93.2% chr15 + 81502440 81503046 607 browser details YourSeq 150 2185 2613 3000 89.1% chr13 - 50375153 50375581 429 browser details YourSeq 143 2465 2657 3000 91.4% chr4 - 129539469 129539822 354 browser details YourSeq 143 2426 2617 3000 86.7% chrX + 122849010 122849189 180 browser details YourSeq 143 2449 2614 3000 94.5% chr1 + 126907735 126907902 168 browser details YourSeq 142 2427 2612 3000 88.1% chr13 - 12075775 12075947 173 browser details YourSeq 142 2454 3000 3000 82.0% chr10 - 4229975 4230390 416 browser details YourSeq 142 2454 2622 3000 94.0% chr9 + 48980238 48980407 170 browser details YourSeq 142 2432 2613 3000 92.9% chr19 + 49331299 49331492 194 browser details YourSeq 141 2445 2637 3000 90.9% chr17 - 28403876 28404070 195 browser details YourSeq 139 2423 2611 3000 89.1% chrX + 107964171 107964379 209 browser details YourSeq 137 2434 2612 3000 87.7% chr7 - 19506027 19506190 164 browser details YourSeq 136 2459 2622 3000 91.9% chr18 - 81003345 81003514 170 browser details YourSeq 135 2426 2612 3000 85.3% chr14 + 109731901 109732075 175 Note: The 3000 bp section downstream of Exon 4 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Clstn1 calsyntenin 1 [ Mus musculus (house mouse) ] Gene ID: 65945, updated on 12-Aug-2019 Gene summary Official Symbol Clstn1 provided by MGI Official Full Name calsyntenin 1 provided by MGI Primary source MGI:MGI:1929895 See related Ensembl:ENSMUSG00000039953 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Cst-1; Cstn1; 1810034E21Rik Expression Broad expression in cortex adult (RPKM 93.0), frontal lobe adult (RPKM 80.3) and 23 other tissues See more Orthologs human all Genomic context Location: 4; 4 E2 See Clstn1 in Genome Data Viewer Exon count: 21 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 4 NC_000070.6 (149585111..149648899) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 4 NC_000070.5 (148960747..149022008) Chromosome 4 - NC_000070.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 4 transcripts Gene: Clstn1 ENSMUSG00000039953 Description calsyntenin 1 [Source:MGI Symbol;Acc:MGI:1929895] Gene Synonyms 1810034E21Rik, Cst-1, alcadein alpha, calsyntenin-1 Location Chromosome 4: 149,586,468-149,648,899 forward strand. GRCm38:CM000997.2 About this gene This gene has 4 transcripts (splice variants), 205 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 15 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Clstn1-202 ENSMUST00000105691.7 4459 969aa ENSMUSP00000101316.1 Protein coding CCDS71522 Q9EPL2 TSL:1 GENCODE basic APPRIS ALT2 Clstn1-201 ENSMUST00000039144.6 3319 979aa ENSMUSP00000036962.6 Protein coding CCDS18963 Q9EPL2 TSL:1 GENCODE basic APPRIS P3 Clstn1-204 ENSMUST00000151895.1 822 No protein - Retained intron - - TSL:2 Clstn1-203 ENSMUST00000137232.1 358 No protein - lncRNA - - TSL:3 Page 6 of 8 https://www.alphaknockout.com 82.43 kb Forward strand 149.58Mb 149.60Mb 149.62Mb 149.64Mb Genes (Comprehensive set... Clstn1-202 >protein coding Clstn1-201 >protein coding Clstn1-203 >lncRNA Clstn1-204 >retained intron Contigs AL607078.26 > Genes < Pik3cd-204protein coding (Comprehensive set... < Pik3cd-201protein coding < Pik3cd-214protein coding < Pik3cd-206protein coding < Pik3cd-205protein coding < Pik3cd-202protein coding < Pik3cd-203protein coding < Mir7023-201miRNA Regulatory Build 149.58Mb 149.60Mb 149.62Mb 149.64Mb Reverse strand 82.43 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding processed transcript RNA gene Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000039144 61.26 kb Forward strand Clstn1-201 >protein coding ENSMUSP00000036... Transmembrane heli... PDB-ENSP mappings MobiDB lite Low complexity (Seg) Coiled-coils (Ncoils) Cleavage site (Sign... Superfamily Cadherin-like superfamily Concanavalin A-like lectin/glucanase domain superfamily SMART Cadherin-like Prints Cadherin-like Pfam Cadherin-like PF13385 PROSITE profiles PS50268 PANTHER Calsyntenin PTHR14139:SF4 Gene3D 2.60.40.60 2.60.120.200 CDD cd11304 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant splice region variant synonymous variant Scale bar 0 100 200 300 400 500 600 700 800 979 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • Effects of Chronic Stress on Prefrontal Cortex Transcriptome in Mice Displaying Different Genetic Backgrounds
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector J Mol Neurosci (2013) 50:33–57 DOI 10.1007/s12031-012-9850-1 Effects of Chronic Stress on Prefrontal Cortex Transcriptome in Mice Displaying Different Genetic Backgrounds Pawel Lisowski & Marek Wieczorek & Joanna Goscik & Grzegorz R. Juszczak & Adrian M. Stankiewicz & Lech Zwierzchowski & Artur H. Swiergiel Received: 14 May 2012 /Accepted: 25 June 2012 /Published online: 27 July 2012 # The Author(s) 2012. This article is published with open access at Springerlink.com Abstract There is increasing evidence that depression signaling pathway (Clic6, Drd1a,andPpp1r1b). LA derives from the impact of environmental pressure on transcriptome affected by CMS was associated with genetically susceptible individuals. We analyzed the genes involved in behavioral response to stimulus effects of chronic mild stress (CMS) on prefrontal cor- (Fcer1g, Rasd2, S100a8, S100a9, Crhr1, Grm5,and tex transcriptome of two strains of mice bred for high Prkcc), immune effector processes (Fcer1g, Mpo,and (HA)and low (LA) swim stress-induced analgesia that Igh-VJ558), diacylglycerol binding (Rasgrp1, Dgke, differ in basal transcriptomic profiles and depression- Dgkg,andPrkcc), and long-term depression (Crhr1, like behaviors. We found that CMS affected 96 and 92 Grm5,andPrkcc) and/or coding elements of dendrites genes in HA and LA mice, respectively. Among genes (Crmp1, Cntnap4,andPrkcc) and myelin proteins with the same expression pattern in both strains after (Gpm6a, Mal,andMog). The results indicate significant CMS, we observed robust upregulation of Ttr gene contribution of genetic background to differences in coding transthyretin involved in amyloidosis, seizures, stress response gene expression in the mouse prefrontal stroke-like episodes, or dementia.
    [Show full text]
  • Single Cell Derived Clonal Analysis of Human Glioblastoma Links
    SUPPLEMENTARY INFORMATION: Single cell derived clonal analysis of human glioblastoma links functional and genomic heterogeneity ! Mona Meyer*, Jüri Reimand*, Xiaoyang Lan, Renee Head, Xueming Zhu, Michelle Kushida, Jane Bayani, Jessica C. Pressey, Anath Lionel, Ian D. Clarke, Michael Cusimano, Jeremy Squire, Stephen Scherer, Mark Bernstein, Melanie A. Woodin, Gary D. Bader**, and Peter B. Dirks**! ! * These authors contributed equally to this work.! ** Correspondence: [email protected] or [email protected]! ! Supplementary information - Meyer, Reimand et al. Supplementary methods" 4" Patient samples and fluorescence activated cell sorting (FACS)! 4! Differentiation! 4! Immunocytochemistry and EdU Imaging! 4! Proliferation! 5! Western blotting ! 5! Temozolomide treatment! 5! NCI drug library screen! 6! Orthotopic injections! 6! Immunohistochemistry on tumor sections! 6! Promoter methylation of MGMT! 6! Fluorescence in situ Hybridization (FISH)! 7! SNP6 microarray analysis and genome segmentation! 7! Calling copy number alterations! 8! Mapping altered genome segments to genes! 8! Recurrently altered genes with clonal variability! 9! Global analyses of copy number alterations! 9! Phylogenetic analysis of copy number alterations! 10! Microarray analysis! 10! Gene expression differences of TMZ resistant and sensitive clones of GBM-482! 10! Reverse transcription-PCR analyses! 11! Tumor subtype analysis of TMZ-sensitive and resistant clones! 11! Pathway analysis of gene expression in the TMZ-sensitive clone of GBM-482! 11! Supplementary figures and tables" 13" "2 Supplementary information - Meyer, Reimand et al. Table S1: Individual clones from all patient tumors are tumorigenic. ! 14! Fig. S1: clonal tumorigenicity.! 15! Fig. S2: clonal heterogeneity of EGFR and PTEN expression.! 20! Fig. S3: clonal heterogeneity of proliferation.! 21! Fig.
    [Show full text]
  • 1 Fibrillar Αβ Triggers Microglial Proteome Alterations and Dysfunction in Alzheimer Mouse 1 Models 2 3 4 Laura Sebastian
    bioRxiv preprint doi: https://doi.org/10.1101/861146; this version posted December 2, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Fibrillar triggers microglial proteome alterations and dysfunction in Alzheimer mouse 2 models 3 4 5 Laura Sebastian Monasor1,10*, Stephan A. Müller1*, Alessio Colombo1, Jasmin König1,2, Stefan 6 Roth3, Arthur Liesz3,4, Anna Berghofer5, Takashi Saito6,7, Takaomi C. Saido6, Jochen Herms1,4,8, 7 Michael Willem9, Christian Haass1,4,9, Stefan F. Lichtenthaler 1,4,5# & Sabina Tahirovic1# 8 9 1 German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany 10 2 Faculty of Chemistry, Technical University of Munich, Garching, Germany 11 3 Institute for Stroke and Dementia Research (ISD), Ludwig-Maximilians Universität München, 12 81377 Munich, Germany 13 4 Munich Cluster for Systems Neurology (SyNergy), Munich, Germany 14 5 Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, 15 Munich, Germany 16 6 Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science Institute, Wako, 17 Saitama 351-0198, Japan 18 7 Department of Neurocognitive Science, Nagoya City University Graduate School of Medical 19 Science, Nagoya, Aichi 467-8601, Japan 20 8 Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, 81377 21 Munich, Germany 22 9 Biomedical Center (BMC), Ludwig-Maximilians Universität München, 81377 Munich, Germany 23 10 Graduate School of Systemic Neuroscience, Ludwig-Maximilians-University Munich, Munich, 24 Germany. 25 *Contributed equally 26 #Correspondence: [email protected] and [email protected] 27 28 Running title: 29 Microglial proteomic signatures of AD 30 Keywords: Alzheimer’s disease / microglia / proteomic signatures / neuroinflammation / 31 phagocytosis 32 1 bioRxiv preprint doi: https://doi.org/10.1101/861146; this version posted December 2, 2019.
    [Show full text]
  • Using Categories Defined by Chromosome Bands
    Using Categories defined by Chromosome Bands D. Sarkar, S. Falcon, R. Gentleman August 7, 2008 1 Chromosome bands Typically, in higher organisms, each chromosome has a centromere and two arms. The short arm is called the p arm and the longer arm the q arm. Chromosome bands (see Figure 1) are identified by differential staining, usually with Giemsa-based stains, and many disease-related defects have been mapped to these bands; such mappings have played an important role in classical cytogenetics. With the availability of complete sequences for several genomes, there have been efforts to link these bands with specific sequence locations (Furey and Haussler, 2003). The estimated location of the bands in the reference genomes can be obtained from the UCSC genome browser, and data linking genes to particular bands can be obtained from a variety of sources such as the NCBI. This vignette demonstrates tools that allow the use of categories derived from chromosome bands, that is, the relevant categories are determined a priori by a mapping of genes to chromosome bands. Figure 1 shows an ideogram of human chromosome 12, with the band 12q21 shaded. As shown in the figure, 12q21 can be divided into more granular levels 12q21.1, 12q21.2, and 12q21.3. 12q21.3 can itself be divided at an even finer level of resolution into 12q21.31, 12q21.32, and 12q21.33. Moving towards less granular bands, 12q21 is a part of 12q2 which is again a part of 12q. We take advantage of this nested structure of the bands in our analysis.
    [Show full text]
  • Oxidized Phospholipids Regulate Amino Acid Metabolism Through MTHFD2 to Facilitate Nucleotide Release in Endothelial Cells
    ARTICLE DOI: 10.1038/s41467-018-04602-0 OPEN Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells Juliane Hitzel1,2, Eunjee Lee3,4, Yi Zhang 3,5,Sofia Iris Bibli2,6, Xiaogang Li7, Sven Zukunft 2,6, Beatrice Pflüger1,2, Jiong Hu2,6, Christoph Schürmann1,2, Andrea Estefania Vasconez1,2, James A. Oo1,2, Adelheid Kratzer8,9, Sandeep Kumar 10, Flávia Rezende1,2, Ivana Josipovic1,2, Dominique Thomas11, Hector Giral8,9, Yannick Schreiber12, Gerd Geisslinger11,12, Christian Fork1,2, Xia Yang13, Fragiska Sigala14, Casey E. Romanoski15, Jens Kroll7, Hanjoong Jo 10, Ulf Landmesser8,9,16, Aldons J. Lusis17, 1234567890():,; Dmitry Namgaladze18, Ingrid Fleming2,6, Matthias S. Leisegang1,2, Jun Zhu 3,4 & Ralf P. Brandes1,2 Oxidized phospholipids (oxPAPC) induce endothelial dysfunction and atherosclerosis. Here we show that oxPAPC induce a gene network regulating serine-glycine metabolism with the mitochondrial methylenetetrahydrofolate dehydrogenase/cyclohydrolase (MTHFD2) as a cau- sal regulator using integrative network modeling and Bayesian network analysis in human aortic endothelial cells. The cluster is activated in human plaque material and by atherogenic lipo- proteins isolated from plasma of patients with coronary artery disease (CAD). Single nucleotide polymorphisms (SNPs) within the MTHFD2-controlled cluster associate with CAD. The MTHFD2-controlled cluster redirects metabolism to glycine synthesis to replenish purine nucleotides. Since endothelial cells secrete purines in response to oxPAPC, the MTHFD2- controlled response maintains endothelial ATP. Accordingly, MTHFD2-dependent glycine synthesis is a prerequisite for angiogenesis. Thus, we propose that endothelial cells undergo MTHFD2-mediated reprogramming toward serine-glycine and mitochondrial one-carbon metabolism to compensate for the loss of ATP in response to oxPAPC during atherosclerosis.
    [Show full text]
  • A Genome-Wide Map of Circular Rnas in Adult Zebrafish
    www.nature.com/scientificreports OPEN A genome-wide map of circular RNAs in adult zebrafsh Disha Sharma1,3, Paras Sehgal2,3, Samatha Mathew2,3, Shamsudheen Karuthedath Vellarikkal2,3, Angom Ramcharan Singh2, Shruti Kapoor1,3, Rijith Jayarajan2, Vinod Scaria1,3 & 2,3 Received: 10 May 2016 Sridhar Sivasubbu Accepted: 3 September 2018 Circular RNAs (circRNAs) are transcript isoforms generated by back-splicing of exons and circularisation Published: xx xx xxxx of the transcript. Recent genome-wide maps created for circular RNAs in humans and other model organisms have motivated us to explore the repertoire of circular RNAs in zebrafsh, a popular model organism. We generated RNA-seq data for fve major zebrafsh tissues - Blood, Brain, Heart, Gills and Muscle. The repertoire RNA sequence reads left over after reference mapping to linear transcripts were used to identify unique back-spliced exons utilizing a split-mapping algorithm. Our analysis revealed 3,428 novel circRNAs in zebrafsh. Further in-depth analysis suggested that majority of the circRNAs were derived from previously well-annotated protein-coding and long noncoding RNA gene loci. In addition, many of the circular RNAs showed extensive tissue specifcity. We independently validated a subset of circRNAs using polymerase chain reaction (PCR) and divergent set of primers. Expression analysis using quantitative real time PCR recapitulate selected tissue specifcity in the candidates studied. This study provides a comprehensive genome-wide map of circular RNAs in zebrafsh tissues. Te recent years have seen an in-depth annotation of transcriptome using next-generation sequencing technol- ogies, signifcantly enhancing the repertoire of transcripts and transcript isoforms identifed for protein-coding as well as noncoding RNA genes1.
    [Show full text]
  • An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
    The Journal of Neuroscience, September 3, 2014 • 34(36):11929–11947 • 11929 Cellular/Molecular An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex Ye Zhang,1* Kenian Chen,2,3* Steven A. Sloan,1* Mariko L. Bennett,1 Anja R. Scholze,1 Sean O’Keeffe,4 Hemali P. Phatnani,4 XPaolo Guarnieri,7,9 Christine Caneda,1 Nadine Ruderisch,5 Shuyun Deng,2,3 Shane A. Liddelow,1,6 Chaolin Zhang,4,7,8 Richard Daneman,5 Tom Maniatis,4 XBen A. Barres,1† and XJia Qian Wu2,3† 1Department of Neurobiology, Stanford University School of Medicine, Stanford, California 94305-5125, 2The Vivian L. Smith Department of Neurosurgery, University of Texas Medical School at Houston, Houston, Texas 77057, 3Center for Stem Cell and Regenerative Medicine, University of Texas Brown Institute of Molecular Medicine, Houston, Texas 77057, 4Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, New York 10032, 5Department of Anatomy, University of California, San Francisco, San Francisco, California 94143-0452, 6Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Victoria, Australia 3010, and 7Department of Systems Biology, 8Center for Motor Neuron Biology and Disease, and 9Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York 10032 The major cell classes of the brain differ in their developmental processes, metabolism, signaling, and function. To better understand the functions and interactions of the cell types that comprise these classes, we acutely purified representative populations of neurons, astrocytes, oligodendrocyte precursor cells, newly formed oligodendrocytes, myelinating oligodendrocytes, microglia, endothelial cells, and pericytes from mouse cerebral cortex.
    [Show full text]
  • Vast Human-Specific Delay in Cortical Ontogenesis Associated With
    Supplementary information Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques Supplementary Methods Sample collection We used prefrontal cortex (PFC) and cerebellar cortex (CBC) samples from postmortem brains of 33 human (aged 0-98 years), 14 chimpanzee (aged 0-44 years) and 44 rhesus macaque individuals (aged 0-28 years) (Table S1). Human samples were obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, USA, the Netherlands Brain Bank, Amsterdam, Netherlands and the Chinese Brain Bank Center, Wuhan, China. Informed consent for use of human tissues for research was obtained in writing from all donors or their next of kin. All subjects were defined as normal by forensic pathologists at the corresponding brain bank. All subjects suffered sudden death with no prolonged agonal state. Chimpanzee samples were obtained from the Yerkes Primate Center, GA, USA, the Anthropological Institute & Museum of the University of Zürich-Irchel, Switzerland and the Biomedical Primate Research Centre, Netherlands (eight Western chimpanzees, one Central/Eastern and five of unknown origin). Rhesus macaque samples were obtained from the Suzhou Experimental Animal Center, China. All non-human primates used in this study suffered sudden deaths for reasons other than their participation in this study and without any relation to the tissue used. CBC dissections were made from the cerebellar cortex. PFC dissections were made from the frontal part of the superior frontal gyrus. All samples contained an approximately 2:1 grey matter to white matter volume ratio. RNA microarray hybridization RNA isolation, hybridization to microarrays, and data preprocessing were performed as described previously (Khaitovich et al.
    [Show full text]
  • (NF1) As a Breast Cancer Driver
    INVESTIGATION Comparative Oncogenomics Implicates the Neurofibromin 1 Gene (NF1) as a Breast Cancer Driver Marsha D. Wallace,*,† Adam D. Pfefferle,‡,§,1 Lishuang Shen,*,1 Adrian J. McNairn,* Ethan G. Cerami,** Barbara L. Fallon,* Vera D. Rinaldi,* Teresa L. Southard,*,†† Charles M. Perou,‡,§,‡‡ and John C. Schimenti*,†,§§,2 *Department of Biomedical Sciences, †Department of Molecular Biology and Genetics, ††Section of Anatomic Pathology, and §§Center for Vertebrate Genomics, Cornell University, Ithaca, New York 14853, ‡Department of Pathology and Laboratory Medicine, §Lineberger Comprehensive Cancer Center, and ‡‡Department of Genetics, University of North Carolina, Chapel Hill, North Carolina 27514, and **Memorial Sloan-Kettering Cancer Center, New York, New York 10065 ABSTRACT Identifying genomic alterations driving breast cancer is complicated by tumor diversity and genetic heterogeneity. Relevant mouse models are powerful for untangling this problem because such heterogeneity can be controlled. Inbred Chaos3 mice exhibit high levels of genomic instability leading to mammary tumors that have tumor gene expression profiles closely resembling mature human mammary luminal cell signatures. We genomically characterized mammary adenocarcinomas from these mice to identify cancer-causing genomic events that overlap common alterations in human breast cancer. Chaos3 tumors underwent recurrent copy number alterations (CNAs), particularly deletion of the RAS inhibitor Neurofibromin 1 (Nf1) in nearly all cases. These overlap with human CNAs including NF1, which is deleted or mutated in 27.7% of all breast carcinomas. Chaos3 mammary tumor cells exhibit RAS hyperactivation and increased sensitivity to RAS pathway inhibitors. These results indicate that spontaneous NF1 loss can drive breast cancer. This should be informative for treatment of the significant fraction of patients whose tumors bear NF1 mutations.
    [Show full text]
  • Mouse Clstn1 Knockout Project (CRISPR/Cas9)
    https://www.alphaknockout.com Mouse Clstn1 Knockout Project (CRISPR/Cas9) Objective: To create a Clstn1 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Clstn1 gene (NCBI Reference Sequence: NM_023051 ; Ensembl: ENSMUSG00000039953 ) is located on Mouse chromosome 4. 19 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 19 (Transcript: ENSMUST00000039144). Exon 3~9 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Juvenile mice homozygous for a null allele show reduced basal excitatory synaptic transmission, abnormal excitatory postsynaptic currents, enhanced NMDA receptor-dependent long term potentiation, and delayed dendritic spine maturation in CA1 hippocampal pyramidal cells. Exon 3 starts from about 7.32% of the coding region. Exon 3~9 covers 38.88% of the coding region. The size of effective KO region: ~9269 bp. The KO region does not have any other known gene. Page 1 of 9 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 3 4 5 6 7 8 9 19 Legends Exon of mouse Clstn1 Knockout region Page 2 of 9 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 3 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix.
    [Show full text]
  • Data Formats Document Table of Contents
    Data File Formats File format v1.4 Software v1.9.0 Copyright © 2010 Complete Genomics Incorporated. All rights reserved. cPAL and DNB are trademarks of Complete Genomics, Inc. in the US and certain other countries. All other trademarks are the property of their respective owners. Disclaimer of Warranties. COMPLETE GENOMICS, INC. PROVIDES THESE DATA IN GOOD FAITH TO THE RECIPIENT “AS IS.” COMPLETE GENOMICS, INC. MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ANY OTHER STATUTORY WARRANTY. COMPLETE GENOMICS, INC. ASSUMES NO LEGAL LIABILITY OR RESPONSIBILITY FOR ANY PURPOSE FOR WHICH THE DATA ARE USED. Any permitted redistribution of the data should carry the Disclaimer of Warranties provided above. Data file formats are expected to evolve over time. Backward compatibility of any new file format is not guaranteed. Complete Genomics data is for Research Use Only and not for use in the treatment or diagnosis of any human subject. Information, descriptions and specifications in this publication are subject to change without notice. Data Formats Document Table of Contents Table of Contents Preface ........................................................................................................................................................................................... 4 Conventions .................................................................................................................................................................................................
    [Show full text]
  • Data File Formats File Format V1.3 Software V1.8.0
    Data File Formats File format v1.3 Software v1.8.0 Copyright © 2010 Complete Genomics Incorporated. All rights reserved. cPAL and DNB are trademarks of Complete Genomics, Inc. in the US and certain other countries. All other trademarks are the property of their respective owners. Disclaimer of Warranties. COMPLETE GENOMICS, INC. PROVIDES THESE DATA IN GOOD FAITH TO THE RECIPIENT “AS IS.” COMPLETE GENOMICS, INC. MAKES NO REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, OR ANY OTHER STATUTORY WARRANTY. COMPLETE GENOMICS, INC. ASSUMES NO LEGAL LIABILITY OR RESPONSIBILITY FOR ANY PURPOSE FOR WHICH THE DATA ARE USED. Any permitted redistribution of the data should carry the Disclaimer of Warranties provided above. Data file formats are expected to evolve over time. Backward compatibility of any new file format is not guaranteed. Complete Genomics data is for Research Use Only and not for use in the treatment or diagnosis of any human subject. Information, descriptions and specifications in this publication are subject to change without notice. Data Formats Document Table of Contents Table of Contents Preface ...................................................................................................................................................................... 3 Conventions ...............................................................................................................................................................................
    [Show full text]